Setting new standards in information exchange for the pharmaceutical and biotech industry
The Findings are in! CTTI delivers their Recommendations on Integrating Mobile Technology into Clinical Trials at the Mobile Conference
August 11, 2017
Most of us are aware that Mobile technology offers tremendous potential for clinical research, but uncertainty exists about how to use the data that can be captured. CTTI’s newly released recommendations and tools present a pathway for using the information gathered from mobile technologies to accelerate the development and evaluation of urgently needed therapies.
We are delighted to welcome Jennifer Goldsack, MChem, MA, MBA, CPHQ, Clinical Project Manager, CTTI, to the 4th annual Mobile in Clinical Trials event to talk about CTTI’s Mobile Clinical Trials program. Launched three years ago, the program aims to develop recommendations to help develop novel endpoints for use in clinical trials from data generated using mobile technology.
Jennifer shares recommendations and insights from CTTI’s Novel Endpoints Project on:
- Developing an internal process for identifying endpoints
- Strategies for reducing friction throughout the process
- Executing the process
- The science required to validate an endpoint
- A suite of tools developed in the process to help facilitate implementation
Jennifer Goldsack, MChem, MA, MBA, CPHQ
Clinical Project Manager, CTTI
Mobile in Clinical Trials takes place on September 6 in Boston. For more information, please click here.